BIORELEASE CORP
10QSB, EX-27, 2000-11-20
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BIORELEASE CORP, 10QSB, 2000-11-20
Next: CHESAPEAKE BIOLOGICAL LABORATORIES INC, SC 14D9, 2000-11-20



<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000797662
<NAME>                        Biorelease Corp.
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              JUN-30-2001
<PERIOD-START>                                 JUL-01-2000
<PERIOD-END>                                   SEP-30-2000
<EXCHANGE-RATE>                                1.000
<CASH>                                         428
<SECURITIES>                                   0
<RECEIVABLES>                                  34,674
<ALLOWANCES>                                   0
<INVENTORY>                                    15,218
<CURRENT-ASSETS>                               50,320
<PP&E>                                         1,577
<DEPRECIATION>                                 157
<TOTAL-ASSETS>                                 51,897
<CURRENT-LIABILITIES>                          40,565
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       121,242
<OTHER-SE>                                     0
<TOTAL-LIABILITY-AND-EQUITY>                   51,897
<SALES>                                        8,255
<TOTAL-REVENUES>                               8,255
<CGS>                                          2,345
<TOTAL-COSTS>                                  2,345
<OTHER-EXPENSES>                               14,839
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                0
<INCOME-TAX>                                   (8,929)
<INCOME-CONTINUING>                            (185)
<DISCONTINUED>                                 (8,744)
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (8,929)
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission